Advertisement

Clinical PET pp 200-209 | Cite as

Cardiology

  • Dong-Soo Lee
  • Jin-Chul Paeng
  • Myung-Chul Lee
  • E. Edmund Kim
Chapter
  • 251 Downloads

Abstract

The glucose analog 18F-fluorodeoxyglucose (FDG) provided, for the first time, the ability to noninvasively probe and characterize the regional metabolism of glucose as a major fuel substrate of the heart. Positron emission tomography (PET) became a tool for demonstrating the metabolic processes directly in the myocardium. Clinical studies showed the dependency of the heart’s substrate selection on circulatory levels of glucose, free fatty acid, and insulin. Regional 18F-FDG uptake markedly in excess of myocardial blood flow in dysfunctional myocardium after infarction, with chronic coronary artery disease or with ischemic cardiomyopathy, became recognized as a hallmark of myocardial viability or potentially reversible contractile dysfunction. Defined as a blood flow metabolism mismatch (Fig. 12.1), the regional glucose uptake pattern identifies patients as being at high risk of cardiac events and identifies patients who will benefit most from surgical revascularization. The patterns predict a postrevascularization improvement in global left ventricular function, in symptoms related to congestive heart failure, and in longterm survival.

Keywords

Positron Emission Tomography Myocardial Perfusion Myocardial Blood Flow Perfusible Tissue Index Rest Perfusion Defect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Schelbert HR. F-18 deoxyglucose and the assessment of myocardial viability. Semin Nucl Med 2002; 27: 60–69.Google Scholar
  2. 2.
    Sandler MP, Bax JJ, Patton JA, et al. Fluorine-18-fluorodeoxyglucose cardiac imaging using a modified scintillation camera. J Nucl Med 1998; 39: 2035–2043.PubMedGoogle Scholar
  3. 3.
    Porenta G, Cherry S, Czernin J, et al. Noninvasive determination of myocardial blood flow, oxygen consumption and efficiency in normal humans by carbon-11 acetate positron emission tomography imaging. Eur J Nucl Med 1999; 26: 1465–1574.PubMedCrossRefGoogle Scholar
  4. 4.
    Auerbach MA, Schoeder H, Hoh C, et al. Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy. Circulation 1999; 99: 2921–2926.PubMedCrossRefGoogle Scholar
  5. 5.
    Bax JJ, Wijns W, Cornel JH, et al. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction. J Am Coll Cardiol 1997; 30: 1452–1460.Google Scholar
  6. 6.
    Srinivasan G, Kitsiou AN, Bachrach SL, et al. [18F] Fluorodeoxyglucose single photon emission computed tomography. Can it replace PET and thallium SPECT for the assessment of myocardial viability? Circulation 1998; 97: 843–850.PubMedCrossRefGoogle Scholar
  7. 7.
    Di Carli M, Davidson M, Little R, et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994; 73: 527–533.PubMedCrossRefGoogle Scholar
  8. 8.
    Bax JJ, Cornel JH, Visser FC, et al. Comparison of fluorine-18-FDG with rest-redistribution thallium-201 SPECT to delineate viable myocardium and predict functional recovery after revascularization. J Nucl Med 1998; 39: 1481–1486.PubMedGoogle Scholar
  9. 9.
    Bax JJ, Cornel JH, Visser FC, et al. Prediction of improvement of contractile function in patients with ischemic ventricular dysfunction after revascularization by fluorine-18 fluorodeoxyglucose single-photon emission computed tomography. J Am Coll Cardiol 1997; 30: 377–383.PubMedCrossRefGoogle Scholar
  10. 10.
    Dietlein M, Knapp WH, Lauterbach KW, Schicha H. Economic evaluation studies in nuclear medicine. Eur J Nucl Med 1999; 26: 553–580.CrossRefGoogle Scholar
  11. 11.
    Patterson RE, Eisner RL, Horowitz SF. Comparison of cost-effectiveness and utility of exercise ECG, single photon emission computed tomography, positron emission tomography, and coronary angiography for diagnosis of coronary artery disease. Circulation 1995; 91: 54–65.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2004

Authors and Affiliations

  • Dong-Soo Lee
  • Jin-Chul Paeng
  • Myung-Chul Lee
  • E. Edmund Kim

There are no affiliations available

Personalised recommendations